{"text": ["3", "Top", "Dogs", "of", "the", "Dow", "Stocks", "to", "Own", "Heading", "Into", "2020"], "created_at": "2019-12-18 19:38:12"}
{"text": ["U.S.", "FDA", "Accepts", "and", "Grants", "Priority", "Review", "to", "sNDA", "for", "BRAFTOVI\u00ae", "(encorafenib)", "in", "Combination", "with", "ERBITUX\u00ae", "(cetuximab)", "(BRAFTOVI", "Doublet)", "for", "the", "Treatment", "of", "BRAFV600E-Mutant", "Metastatic", "Colorectal", "Cancer", "After", "Prior", "Therapy"], "created_at": "2019-12-18 15:30:00"}
{"text": ["Pfizer", "and", "Mylan", "Announce", "Two", "Future", "Viatris", "Board", "Members"], "created_at": "2019-12-18 13:30:00"}
{"text": ["Lilly's", "Stock", "Up", "on", "Upbeat", "Sales", "&", "Profit", "Outlook", "for", "2020"], "created_at": "2019-12-18 13:21:01"}
